LIGHTSWITCH CAPITAL MANAGEMENT, L.P.
LIGHTSWITCH CAPITAL MANAGEMENT, L.P. is a Series C+ fund in the US investing in AI, Healthcare and biotechnology.
- Stages
- Series C+
- Sectors
- AI, Healthcare, biotechnology
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2021
- Assets under management
- $34.6M
Check size not disclosed
Thesis
Lightswitch Capital Management, L.P. is a private equity firm based in New York City, founded in 2021. The firm primarily focuses on investments within the healthcare and biotechnology sectors, aiming to empower companies developing innovative solutions by providing strategic capital and operational support to accelerate their growth and enhance their market presence. Their investment thesis centers on identifying and partnering with private healthcare and biotech ventures that require capital and strategic expertise, with a vision to contribute to the evolution of the healthcare industry by supporting enterprises poised for substantial impact. They actively seek opportunities that align with their commitment to advancing medical and biotechnological solutions. The firm appears to invest in later-stage venture capital deals, with a notable Series C investment in Alto Neuroscience in November 2023 and an investment in Hinge Bio in January 2025. Lightswitch Capital primarily operates within the United States. One filing indicates a "Private Equity Fund" with a Gross Asset Value of $34,596,220.
Common questions
Does LIGHTSWITCH CAPITAL MANAGEMENT, L.P. invest at the Series C+ stage?
Yes. LIGHTSWITCH CAPITAL MANAGEMENT, L.P. lists Series C+ among the stages it invests in.
Where does LIGHTSWITCH CAPITAL MANAGEMENT, L.P. invest?
LIGHTSWITCH CAPITAL MANAGEMENT, L.P. invests in the US.